PreprintAll rights reservedbioRxiv
mTOR drives cerebrovascular dysfunction and blood-brain barrier breakdown in a model of Alzheimers disease with cerebral amyloid angiopathy
- 1University of Oklahoma Health Campus
Related
- APOE4 reduction in vascular-associated fibroblasts decreases cerebral amyloid angiopathy and associated vascular dysfunction
- mTOR disrupts cerebrovascular RNA regulatory networks in Alzheimers disease
- Serpin A3 is Increased in Cerebral Amyloid Angiopathy and ARIA
- Semaphorin 3G (SEMA3G) is a highly selective marker of cerebral amyloid angiopathy
- Integration of Neuroimaging and Histopathology in a Squirrel Monkey Model of Spontaneous Cerebral Amyloid Angiopathy and Amyloid-Related Imaging Abnormalities
BibTeX
@misc{skike2026mtor,
title = {{mTOR drives cerebrovascular dysfunction and blood-brain barrier breakdown in a model of Alzheimers disease with cerebral amyloid angiopathy}},
author = {C. E. Van Skike and L. R. Miller and S. F. Hernandez and S. A. Hussong and H. Makhlouf and A. Muppala and N. DeRosa and J. B. Jahrling and K. T. Dineley and V. Galvan},
howpublished = {bioRxiv},
year = {2026},
month = jun,
doi = {10.64898/2026.06.23.733858},
url = {https://www.biorxiv.org/content/10.64898/2026.06.23.733858v2},
}
RIS
TY - UNPB
TI - mTOR drives cerebrovascular dysfunction and blood-brain barrier breakdown in a model of Alzheimers disease with cerebral amyloid angiopathy
AU - C. E. Van Skike
AU - L. R. Miller
AU - S. F. Hernandez
AU - S. A. Hussong
AU - H. Makhlouf
AU - A. Muppala
AU - N. DeRosa
AU - J. B. Jahrling
AU - K. T. Dineley
AU - V. Galvan
PY - 2026
DA - 2026/06/23
PB - bioRxiv
DO - 10.64898/2026.06.23.733858
UR - https://www.biorxiv.org/content/10.64898/2026.06.23.733858v2
ER -